Mario Alfredo Eisenberger M D , Professor of Oncology Johns Hopkins Medicine Search Popular Searches Find a Doctor or Researcher
Find a Doctor
Find a Researcher
Mario Alfredo Eisenberger M D
Mario Alfredo Eisenberger M D R. Dale Hughes Professor of Oncology and Urology Professor of Oncology Male Languages: English, German, Portuguese, Spanish Expertise
Bladder Cancer, Clinical Trials, Kidney Cancer Research Interests
Urological oncology; Testicular cancer; Prostate Request an Appointment
Existing Patients
Main Phone
Outside of Maryland & Washington D C
International Patients
Locations
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
410-955-8964 401 N. Broadway
Baltimore, MD 21231 Johns Hopkins Medicine - Green Spring Station
410-583-2970 10755 Falls Road
Pavilion I
Lutherville, MD 21093 Sibley Memorial Hospital
202-660-6500 5255 Loughboro Road NW
Washington, DC 20016 Background
Dr. Mario A. Eisenberger is a medical oncologist at Sibley Memorial Hospital, as well as a professor of urology and oncology at the Johns Hopkins University School of Medicine. He is board certified in internal medicine and medical oncology. He practices out of Sibley Memorial Hospital in Washington, D.C., Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Md. and Johns Hopkins Medicine - Green Spring Station in Lutherville, Md. Dr. Eisenberger has an expertise in cancers of the bladder, kidney, prostate and testicles. Dr. Eisenberger earned his medical degree from Federal University of Rio de Janeiro. He completed a residency in internal medicine at Michael Reese Hospital and Medical Center, followed by a hematology fellowship. Dr. Eisenberger also completed a fellowship in medical oncology at Jackson Memorial Hospital. He was previously a senior investigator for the Cancer Therapy Evaluation Program of the National Cancer Institute and chief of oncology at the Baltimore Veterans Administration Hospital. Dr. Dunne has also held faculty appointments at the University of Miami and the University of Maryland. Dr. Eisenberger has been repeatedly named one of America's Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He is a member of the American Association of Cancer Research, the National Prostate Cancer Education Council and the International Task Force of the American Society of Clinical Oncology. Dr. Eisenberger has contributed to numerous clinical trials, publications and presentations. He has presented on the systemic treatment of prostate cancer for the President's Cancer Panel and was a participant in the World Health Organization international panel to update directives and standardize methodology of clinical trials in advanced prostate cancer. Dr. Eisenberger has also won the Clinical Investigator Award by the Prostate Cancer Foundation. Titles
R. Dale Hughes Professor of Oncology and Urology Professor of Oncology Professor of Urology Departments Divisions
- Genitourinary Cancer Disease Centers & Institutes
Education
Degrees
MD; Faculdade De MedicinaCentro De Ciencas (1972) Residencies
Internal Medicine; Michael Reese Hospital and Medical Center (1975) Fellowships
Medical Oncology; Jackson Memorial Hospital (1978) Hematology; Michael Reese Hospital and Medical Center (1976) Board Certifications
American Board of Internal Medicine (Internal Medicine) (1976) American Board of Internal Medicine (Medical Oncology) (1979) Research & Publications
Clinical Trial Keywords
prostate cancer Selected Publications
Peer A, Gottfried M, Sinibaldi V, Carducci MA, Eisenberger MA, Sella A, Leibowitz-Amit R, Berger R, Keizman D. "Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel." Prostate. 2013 Dec 11. doi: 10.1002/pros.22765. [Epub ahead of print]. Keizman D, Gottfried M, Ish-Shalom M, Maimon N, Peer A, Neumann A, Hammers H, Eisenberger MA, Sinibaldi V, Pili R, Hayat H, Kovel S, Sella A, Boursi B, Weitzen R, Mermershtain W, Rouvinov K, Berger R, Carducci MA. "Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib." Oncologist. 2013 Dec 5. [Epub ahead of print]. Paller CJ, Antonarakis ES, Eisenberger MA, Carducci MA. "Management of patients with biochemical recurrence after local therapy for prostate cancer." Hematol Oncol Clin North Am. 2013 Dec;27(6):1205-19, viii. doi: 10.1016/j.hoc.2013.08.005. Epub 2013 Sep 18. Suzman DL, Eisenberger MA. "Determining the Optimal Treatment for Metastatic Castration-resistant Prostate Cancer: Age Should Not Be a Factor." Eur Urol. 2013 Oct 16. pii: S0302-2838(13)01075-0. doi: 10.1016/j.eururo.2013.10.002. [Epub ahead of print] Pond GR, Sonpavde G, de Wit R, Eisenberger MA, Tannock IF, Armstrong AJ. 'The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer." Eur Urol. 2014 Jan;65(1):3-6. doi: 10.1016/j.eururo.2013.09.024. Epub 2013 Oct 5. Activities & Honors
Honors
Clinical Investigator Award, Prostate Cancer Foundation, 2004 Plenary Presentation, American Society of Clinical Oncology, New Orleans, LA, 2004 Listed in Best Doctors of America, 2000 - 2006 R. Dale Hughes Distinguished Professor of Oncology, The Johns Hopkins University, 2002 Plenary Presentation, American Society of Clinical Oncology, Denver CO, 1997 Who's Who in the World, 1995 Participant in World Health Organization international panel to update directives and standardize methodology of clinical trials in advanced prostate cancer, 1995 Selected to present on the systemic treatment of prostate cancer for the President's Cancer Panel, 1992 Selected as member of Prostate Cancer Education Council, 1989 Participant in NIH Consensus Conference in Prostate Cancer, 1987 Memberships
American Association of Cancer Research American Society of Clinical Oncology National Prostate Cancer Education Council